Paid Clinical Trials Birmingham

Discover 910 paid clinical trials in Birmingham, Alabama. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 910

Investigational CMV Vaccine Study for Volunteers Ages 9–15Investigational CMV Vaccine Study for Volunteers Ages 9–15

PHASE1

PHASE2

Sponsor:

Moderna

Location:

Birmingham AL, Columbus GA, Atlanta GA, Decatur GAshow 43 more

Code:

NCT05575492

Conditions

Cytomegalovirus

Eligibility Criteria

Sex: All

Age: 9 - 15

Healthy Volunteers: Accepted

Interventions

mRNA-1647

Placebo

ImmunotherapyImmunotherapy Before and After Surgery for Treatment of Recurrent or Progressive High Grade Glioma in Children and Young Adults

Recruiting

PHASE1

Sponsor:

Sabine Mueller, MD, PhD

Location:

Birmingham AL, Gainesville FL, Saint Louis MO, Indianapolis INshow 9 more

Code:

NCT04323046

Conditions

Glioblastoma

Malignant Glioma

Recurrent Glioblastoma

Recurrent Malignant Glioma

Recurrent Grade III Glioma

Eligibility Criteria

Sex: All

Age: 6 - 25

Healthy Volunteers: Not accepted

Interventions

Nivolumab

Quality-of-Life Assessment

Questionnaire Administration

PF-08046054A Study of SGN-PDL1V in Advanced Solid Tumors

Recruiting

PHASE1

Sponsor:

Seagen Inc.

Location:

Birmingham AL, Houston TX, Cleveland OH, Iowa City IAshow 8 more

Code:

NCT05208762

Conditions

Carcinoma, Non-Small-Cell Lung

Squamous Cell Carcinoma of the Head and Neck

Esophageal Squamous Cell Carcinoma

Ovarian Neoplasms

Melanoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

PF-08046054

pembrolizumab

Efgartigimod PH20A Study to Evaluate the Safety and Tolerability of Efgartigimod PH20 SC Given by Prefilled Syringe in Kidney Transplant Recipients With Antibody-Mediated Rejection (AMR)

Recruiting

PHASE2

Sponsor:

argenx

Location:

Birmingham AL, Durham NC, Columbus OH, Richmond VAshow 2 more

Code:

NCT06503731

Conditions

Antibody-mediated Rejection

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Efgartigimod PH20 SC - prefilled syringe

Placebo PH20 SC - prefilled syringe

AB-101 & B-Cell Depleting mAbAB-101 in Combination With B-Cell Depleting mAb in Patients Who Failed Treatment for Class III or IV Lupus Nephritis or Other Forms of Refractory Systemic Lupus Erythematosus

Recruiting

PHASE1

Sponsor:

Artiva Biotherapeutics, Inc.

Location:

Birmingham AL, San Diego CA

Code:

NCT06265220

Conditions

Lupus Nephritis - WHO Class III

Lupus Nephritis - WHO Class IV

Refractory Systemic Lupus Erythematosus

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

AB-101

Cyclophosphamide

Fludarabine

Rituximab

Obinutuzumab

Nivolumab & TovorafenibNivolumab and Tovorafenib for Treatment of Craniopharyngioma in Children and Young Adults

Recruiting

PHASE2

Sponsor:

Sabine Mueller, MD, PhD

Location:

Birmingham AL, Saint Louis MO, Indianapolis IN, Durham NCshow 11 more

Code:

NCT05465174

Conditions

Craniopharyngioma, Child

Craniopharyngioma

Recurrent Craniopharyngioma

Eligibility Criteria

Sex: All

Age: 1 - 39

Healthy Volunteers: Not accepted

Interventions

Nivolumab

Tovorafenib

PegozaferminA Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH

Recruiting

PHASE3

Sponsor:

89bio, Inc.

Location:

Homewood AL, Nashville TN, Hermitage TN, Athens GAshow 89 more

Code:

NCT06419374

Conditions

Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Pegozafermin

Placebo

177Lu-DOTATATE vs. EverolimusComparing Retreatment of 177Lu-DOTATATE PRRT Versus Everolimus in Patients With Metastatic Unresectable Midgut Neuroendocrine Tumors, NET RETREAT Trial

Recruiting

PHASE2

Sponsor:

National Cancer Institute (NCI)

Location:

Birmingham AL, Lexington KY, Jacksonville FL, Columbus OHshow 22 more

Code:

NCT05773274

Conditions

Metastatic Midgut Neuroendocrine Tumor

Metastatic Midgut Neuroendocrine Tumor G1

Metastatic Midgut Neuroendocrine Tumor G2

Unresectable Midgut Neuroendocrine Tumor

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Biospecimen Collection

Computed Tomography

Everolimus

Lutetium Lu 177 Dotatate

Quality-of-Life Assessment

Harmony TPVHarmony TPV Post-Approval Study

Recruiting

Sponsor:

Medtronic Cardiovascular

Location:

Birmingham AL, Charlotte NC, Saint Louis MO, Charleston SCshow 17 more

Code:

NCT05077774

Conditions

Congenital Heart Disease

Tetrology of Fallot

RVOT Anomaly

Pulmonary Regurgitation

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Not accepted

Interventions

Harmony TPV System

LitifilimabA 2-Part Study to Learn Whether Litifilimab (BIIB059) Injections Can Improve Symptoms of Adult Participants Who Have Active Cutaneous Lupus Erythematosus (AMETHYST)

Recruiting

PHASE2

PHASE3

Sponsor:

Biogen

Location:

Birmingham AL, Anniston AL, Nashville TN, New Orleans LAshow 51 more

Code:

NCT05531565

Conditions

Subacute Cutaneous Lupus Erythematosus

Chronic Cutaneous Lupus Erythematosus

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Litifilimab

Placebo

Chemotherapy with Endocrine TherapyEvaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

Recruiting

PHASE3

Sponsor:

NRG Oncology

Location:

Birmingham AL, Columbus MS, Newnan GA, Fayetteville GAshow 715 more

Code:

NCT05879926

Conditions

Breast Cancer

Eligibility Criteria

Sex: Female

Age: 18 - 60

Healthy Volunteers: Not accepted

Interventions

Ovarian Function Suppression + Aromatase Inhibitor

Adjuvant Chemotherapy + Ovarian Function Suppression